Clinical Trials Browser

Phase EARLY_PHASE1 × Completed × Vinorelbine × Clear all

NCT02802748 2018-09-20

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

Phase EARLY_PHASE1 Completed

Breast Neoplasms